The global radiation dose management market size reached USD 344.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 976.1 Million by 2033, exhibiting a growth rate (CAGR) of 11.64% during 2025-2033. Extensive research and development (R&D) activities, escalating growth in the healthcare industry, and increasing incidences of chronic diseases, such as cancer, represent some of the key factors driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 344.8 Million |
Market Forecast in 2033
|
USD 976.1 Million |
Market Growth Rate (2025-2033) | 11.64% |
Radiation dose management refers to a medical system used to optimize, regulate, or block doses through barriers or computed tomography (CT) reduction technologies. It includes information of tools for monitoring patient exposure, optimization, quality assurance, dose management, and real-time staff dose monitoring. It helps radiographers, medical practitioners, medical physics experts (MPE), and other health professionals involved in imaging. Radiation dose management assists in facilitating data collection and processing, statistical comparisons, reporting, and management of radiation dose-related information. As a result, radiation dose management systems are widely used in hospitals, imaging centers, and research institutes for estimating the dose required for a procedure to prevent high radiation dose exposure to patients.
The increasing utilization of diagnostic imaging modalities across the globe is one of the key factors driving the market growth. Radiation dose management helps in automatically gathering and consolidating the large amounts of dose data generated by imaging modalities. In line with this, the widespread adoption of the technique in ultrasound, magnetic resonance imaging (MRI), computer tomography (CT), positron emission tomography (PET), and X-ray imaging is favoring the market growth. Moreover, the increasing utilization of radiation dose management for identifying, analyzing, and processing significant dose events and exporting dose data for reporting is acting as another growth-inducing factor. Apart from this, the integration of artificial intelligence (AI) and the Internet of Things (IoT) that allows to obtain real-time information on the radiation dose received by patients and improving safety is providing an impetus to the market growth. Additionally, the widespread utilization of radiation dose management, which assists in increasing patient safety by tracking radiation exposure history, is propelling the market growth. Furthermore, the increasing demand for radiation dose management due to its numerous advantages, such as reduced burden of manual collection of doses for CT performed in a center and the early detection of wrong dose selection, is positively influencing the market growth. Besides this, the implementation of various government initiatives to encourage dose management systems due to their increased efficacy is creating a positive outlook for the market. Other factors, including rising expenditure capacities of consumers, extensive research and development (R&D) activities, significant expansion in the healthcare industry, increasing incidences of chronic diseases, such as cancer, and growing awareness about radiation dose management, are anticipated to drive the market growth further.
IMARC Group provides an analysis of the key trends in each segment of the global radiation dose management market, along with forecasts at the global, regional, and country levels from 2025-2033. Our report has categorized the market based on component, modality, application and end user.
Component Insights:
The report has provided a detailed breakup and analysis of the radiation dose management market based on the component. This includes software (integrated and standalone solution) and services. According to the report, software represented the largest segment.
Modality Insights:
The report has provided a detailed breakup and analysis of the radiation dose management market based on the modality. This includes computed tomography, fluoroscopy and interventional imaging, radiography, and mammography, and nuclear medicine. According to the report, computed tomography represented the largest segment.
Application Insights:
The report has provided a detailed breakup and analysis of the radiation dose management market based on the application. This includes oncology, cardiology, orthopedic applications, and others. According to the report, oncology represented the largest segment.
End User Insights:
The report has provided a detailed breakup and analysis of the radiation dose management market based on the end user. This includes hospitals, ambulatory care settings, and others. According to the report, hospitals represented the largest segment.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for radiation dose management. Some of the factors driving the North America radiation dose management market included growing awareness about radiation dose management, extensive research and development (R&D) activities, and various technological innovations.
The report has also provided a comprehensive analysis of the competitive landscape in the global radiation dose management market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Bayer Pharmaceuticals (Bayer AG), General Electric Company, INFINITT Healthcare Co. Ltd., Koninklijke Philips N.V., Medsquare, Novarad Corporation, PACSHealth LLC, Qaelum, Sectra AB, Siemens Healthcare Private Limited (Siemens AG), Volpara Health Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Components Covered |
|
Modalities Covered | Computed Tomography, Fluoroscopy and Interventional Imaging, Radiography and Mammography, Nuclear Medicine |
Applications Covered | Oncology, Cardiology, Orthopedic Applications, Others |
End Users Covered | Hospitals, Ambulatory Care Setting , Others |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Bayer Pharmaceuticals (Bayer AG), General Electric Company, INFINITT Healthcare Co. Ltd., Koninklijke Philips N.V., Medsquare, Novarad Corporation, PACSHealth LLC, Qaelum, Sectra AB, Siemens Healthcare Private Limited (Siemens AG), Volpara Health Limited, etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: